Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 6.3% – Should You Sell?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY)’s stock price dropped 6.3% on Wednesday . The company traded as low as $17.80 and last traded at $17.85. Approximately 24,255 shares were traded during trading, a decline of 95% from the average daily volume of 463,447 shares. The stock had previously closed at $19.05.

Daiichi Sankyo Stock Down 1.7%

The stock’s fifty day moving average is $18.45 and its two-hundred day moving average is $21.17. The company has a debt-to-equity ratio of 0.18, a current ratio of 2.69 and a quick ratio of 1.85. The stock has a market capitalization of $33.73 billion, a P/E ratio of 16.33, a PEG ratio of 0.98 and a beta of -0.04.

Daiichi Sankyo (OTCMKTS:DSNKY) last posted its quarterly earnings data on Thursday, January 29th. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.05. Daiichi Sankyo had a net margin of 14.83% and a return on equity of 18.64%. The firm had revenue of $3.65 billion during the quarter, compared to analyst estimates of $3.88 billion. As a group, research analysts predict that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 1.04 earnings per share for the current fiscal year.

About Daiichi Sankyo

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.